AMY DALEY: Open Payments
NPI 1558616474 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,260 in 88 payments from 12 companies in 2025. Trend: 2023 $2,182 · 2024 $1,852 · 2025 $2,260
Food & beverage: $2,150Education: $110
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $507 |
| ABBVIE INC. | 16 | $316 |
| Arcutis Biotherapeutics, Inc. | 4 | $291 |
| Novartis Pharmaceuticals Corporation | 13 | $258 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $188 |
| Amgen Inc. | 4 | $174 |
| Organon LLC | 5 | $173 |
| GENZYME CORPORATION | 8 | $170 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Lilly USA, LLC | 3 | $62 |
Products named: Bimzelx, Zoryve, COSENTYX, RINVOQ, OTEZLA, DUPIXENT, VTAMA, SKYRIZI.
Industry payments across NY — which companies pay providers there.
